H
harddriver
Well-known member
Funny I don't see them testing anyone for TB, Cholera, Malaria, Typhus or other communicable diseases crossing the US southern border do you?
https://news.yahoo.com/cdc-widens-early-virus-detection-044208345.html
Nov. 6 (UPI) -- The U.S. Centers for Disease Control and Prevention is expanding its infectious disease surveillance program to detect more than 30 bacteria, antimicrobial resistance targets and viruses including influenza A and B, and respiratory syncytial virus, known as RSV, and SARS-CoV-2.
The agency will launch the pilot program in four of America's busiest airports: Boston Logan International Airport, San Francisco International Airport, Dulles International Airport in Washington, D.C., and John F. Kennedy International Airport in New York.
This is an expansion of the agency's Traveler-based Genomic Surveillance program. Samples that test positive will be uploaded to public databases that will help educate and inform public health officials and decision makers about the prevalence of infectious respiratory diseases, such as COVID-19 and other ailments.
The surveillance program, led by CDC's Travelers' Health Branch, was introduced during the COVID-19 pandemic to detect new SARS-CoV-2 variants and other pathogens. Health workers test nasal swab and wastewater samples from passengers arriving on international flights at U.S. airports and volunteer to be tested.
https://news.yahoo.com/cdc-widens-early-virus-detection-044208345.html
Nov. 6 (UPI) -- The U.S. Centers for Disease Control and Prevention is expanding its infectious disease surveillance program to detect more than 30 bacteria, antimicrobial resistance targets and viruses including influenza A and B, and respiratory syncytial virus, known as RSV, and SARS-CoV-2.
The agency will launch the pilot program in four of America's busiest airports: Boston Logan International Airport, San Francisco International Airport, Dulles International Airport in Washington, D.C., and John F. Kennedy International Airport in New York.
This is an expansion of the agency's Traveler-based Genomic Surveillance program. Samples that test positive will be uploaded to public databases that will help educate and inform public health officials and decision makers about the prevalence of infectious respiratory diseases, such as COVID-19 and other ailments.
The surveillance program, led by CDC's Travelers' Health Branch, was introduced during the COVID-19 pandemic to detect new SARS-CoV-2 variants and other pathogens. Health workers test nasal swab and wastewater samples from passengers arriving on international flights at U.S. airports and volunteer to be tested.
Last edited: